However, baseline coping strategies may impact electroacupuncture response
MONDAY, Nov. 2, 2020 (HealthDay News) — Certain patient factors may affect the clinical response to electroacupuncture treatment for low back pain, according to a study published online Oct. 27 in JAMA Network Open.
Jiang-Ti Kong, M.D., from the Stanford University School of Medicine in Palo Alto, California, and colleagues evaluated the effect of real electroacupuncture (59 patients) versus placebo (62 patients) on pain and disability among randomly assigned adults with chronic low back pain for at least six months.
The researchers found that after adjusting for baseline pain scores, there was no statistically significant difference observed between groups for change in National Institutes of Health PROMIS T-scores two weeks after completion of treatment. There was a significantly greater reduction noted in Roland Morris Disability Questionnaire (RMDQ) scores in the real electroacupuncture group versus the sham electroacupuncture group after adjusting for baseline RMDQ score. Effective coping at baseline was associated with greater RMDQ score reduction, while White race was associated with worse PROMIS and RMDQ scores — both within the real electroacupuncture group.
“If validated, these findings may help match people to treatment,” the authors write. “For example, low scores on the coping strategies questionnaire could identify individuals who may need psychological intervention alone or as an augmentation to electroacupuncture.”
Press-Needle Therapy Shows Potential for Pediatric Allergic Rhinitis
Swimming Program May Provide Short-Term Relief From Chronic Low Back Pain
Acupuncture Alleviates Neurological Impairment After Stroke
Electroacupuncture Accelerates Postprostatectomy Urinary Continence Recovery
Risk for Prostate Cancer Elevated With Higher Ultraprocessed Food Intake
Rates of Active Surveillance for Low-Risk Prostate Cancer High for Veterans
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer